Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (284)	12/22/2000 2:21:03 PM
From: tuck	Respond to of 1784

Well, here goes nothing: Trickle buys 100 shares ABI for $85. No SIAL under Trickle's christmas tree. But maybe we can make it the buy of the millenium or some such rubbish. Just in case the market goes to heck one more time and takes SIAL with it. If not, Trickle will watch wistfully, and turn its attention & remaining cash to spin offs, IPO's, lock up expiration buying ops, etc. Xenogen just scored a win with CEGE. Is this preparation for letting it out of the chute? 1Q01 says Trickle. Cheers, Tuck